{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01844063",
      "OrgStudyIdInfo": {
        "OrgStudyId": "The Third Affiliated Hospital"
      },
      "Organization": {
        "OrgFullName": "Third Affiliated Hospital, Sun Yat-Sen University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure",
      "OfficialTitle": "Clinical Comparison of Safety and Efficacy of Allogeneic Umbilical-Cord and Bone Marrow-derived Mesenchymal Stem Cells Transplantation for HBV-related Liver Failure"
    },
    "StatusModule": {
      "StatusVerifiedDate": "July 2013",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "July 2013"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "January 2016",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "January 2019",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "April 20, 2013",
      "StudyFirstSubmitQCDate": "April 27, 2013",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "May 1, 2013",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "July 4, 2013",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "July 8, 2013",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Qi Zhang, MD",
        "ResponsiblePartyInvestigatorTitle": "Deputy Director, Office of International Cooperation & Exchange Office of Hongkong, Macao & Taiwan Affairs",
        "ResponsiblePartyInvestigatorAffiliation": "Third Affiliated Hospital, Sun Yat-Sen University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Third Affiliated Hospital, Sun Yat-Sen University",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "HBV-related liver failure (HBV-LF), a dramatic clinical syndrome, is characterized with massive necrosis of liver cells. Liver transplantation might be the most effective therapy for HBV-LF. However, there are a lot of problems such as lack of donors, surgical complications, transplant rejection, and high cost, which could limit the application of liver transplantation. It is demonstrated that mesenchymal stem cells could directionally differentiate into hepatocytes and cholangiocytes in injured liver, as well as reduce inflammation of the liver by immune regulation. In this study, we assess the safety and efficacy of human bone marrow and umbilical cord mesenchymal stem cells transplantation for patients with HBV-LF."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Liver Failure"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "210",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Conventional treatment",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Participants will receive conventional treatment and then be followed until the week 72 study visit.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Conventional treatment"
              ]
            }
          },
          {
            "ArmGroupLabel": "Conventional plus BM-MSC treatment",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Participants will receive conventional treatment plus a dose of BM-MSC(each subgroups with a different dose ) and then be followed until the week 72 study visit.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Genetic: Conventional plus BM-MSC treatment"
              ]
            }
          },
          {
            "ArmGroupLabel": "Conventional plus UC-MSC treatment",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Participants will receive conventional treatment plus a dose of UC-MSC(each subgroups with a different dose ) and then be followed until the week 72 study visit.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Genetic: Conventional plus UC-MSC treatment"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Genetic",
            "InterventionName": "Conventional plus BM-MSC treatment",
            "InterventionDescription": "Received conventional treatment and bone marrow mesenchymal stem cells transplantation by peripheral vein slowly for 30minutes. (1×10e5/Kg,1×10e6/Kg,or 1×10e7/Kg, once a week, 8 times).",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Conventional plus BM-MSC treatment"
              ]
            }
          },
          {
            "InterventionType": "Genetic",
            "InterventionName": "Conventional plus UC-MSC treatment",
            "InterventionDescription": "Received conventional treatment and bone marrow mesenchymal stem cells transplantation by peripheral vein slowly for 30minutes. (1×10e5/Kg,1×10e6/Kg,or 1×10e7/Kg, once a week, 8 times)",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Conventional plus UC-MSC treatment"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Conventional treatment",
            "InterventionDescription": "Received conventional treatment including:\n\nA.antiviral drugs(Entecavir,Lamivudine,Adefovir dipivoxil,et al); B.Hepatoprotective drugs(Ademetionine1,4-butanethiosulfonate for Injection, Reduced Glutathione for Injection,Polyene Phosphatidylcholine, et al); C.Plasma.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Conventional treatment"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Antiviral drugs",
                "Hepatoprotective drugs",
                "Plasma"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "survival rate",
            "PrimaryOutcomeDescription": "The survival rate and time",
            "PrimaryOutcomeTimeFrame": "72 weeks"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Liver function",
            "SecondaryOutcomeDescription": "The levels of serum Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST),Cholinesterase (CHE) ,Total Bilirubin(TB),Direct Bilirubin(DB), Serum Albumin （ALB）",
            "SecondaryOutcomeTimeFrame": "72 weeks after treatment"
          },
          {
            "SecondaryOutcomeMeasure": "Marker of liver cancer",
            "SecondaryOutcomeDescription": "The level of alpha-fetoprotein (AFP)",
            "SecondaryOutcomeTimeFrame": "72 weeks after treatment"
          },
          {
            "SecondaryOutcomeMeasure": "The degree of hepatic necrosis",
            "SecondaryOutcomeDescription": "The levels of Prothrombin Activity (PA) and Prothrombin Time (PT)",
            "SecondaryOutcomeTimeFrame": "2 years after treatment"
          },
          {
            "SecondaryOutcomeMeasure": "The improvement of symptoms",
            "SecondaryOutcomeDescription": "The improvement of clinical symptoms [including appetite, debilitation, abdominal distension, edema of lower limbs, et al",
            "SecondaryOutcomeTimeFrame": "72 weeks after treatment"
          },
          {
            "SecondaryOutcomeMeasure": "The score for Model for End-Stage Liver Disease",
            "SecondaryOutcomeTimeFrame": "72 weeks after treatment"
          },
          {
            "SecondaryOutcomeMeasure": "The improvement of immune function",
            "SecondaryOutcomeDescription": "cluster of differentiation 4 (CD4+)T/ cluster of differentiation 8 (CD8+)T,T helper cell 1 (Th1)/ T helper cell 1(Th2),natural killer cell(NK),natural killer T(NK T),interleukin-1β(IL-1β),interleukin-4(IL-4),interleukin-6(IL-6),interleukin-8(IL-8),interleukin-12(IL-12),interleukin-15(IL-15),interleukin-17A(IL-17A),Tumor necrosis factor-alpha (TNF-α),Interferon-gamma (IFN-γ)",
            "SecondaryOutcomeTimeFrame": "72 weeks after treatment"
          },
          {
            "SecondaryOutcomeMeasure": "complications",
            "SecondaryOutcomeDescription": "The occurrence of complications [including body temperature, tetter and allergy]",
            "SecondaryOutcomeTimeFrame": "Between 0 to 8 hours after MSC transfusion"
          },
          {
            "SecondaryOutcomeMeasure": "The incidence of hepatocellular carcinoma",
            "SecondaryOutcomeTimeFrame": "72 weeks after treatment"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAged 18-65 years\nLiver failure\nNegative pregnancy test (female patients in fertile age)\nWritten consent\nHBsAg positive\nTB≥171 μmol/L or ascend ≥17.1 μmol/L/per day,\nINR≥1.5 or 20%<PTA≤40%\n17≤MELD score≤30\n\nExclusion Criteria:\n\nHepatocellular carcinoma or other malignancies\nSevere problems in other vital organs(e.g.the heart,renal or lungs)\nPregnant or lactating women\nSevere bacteria infection\nAnticipated with difficulty of follow-up observation\nLiver failure caused by other reasons, such as autoimmune diseases, alcohol, drug and so on\nOther candidates who are judged to be not applicable to this study by doctors",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Qihuan Xu, Doctor",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+86 20 85253179",
            "CentralContactEMail": "xqh0303@yahoo.com"
          },
          {
            "CentralContactName": "Qi Zhang, Doctor",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+86 20 85253106",
            "CentralContactEMail": "kee_kee@126.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Qi Zhang, Doctor",
            "OverallOfficialAffiliation": "Third Affiliated Hospital, Sun Yat-Sen University",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Qi Zhang",
            "LocationStatus": "Recruiting",
            "LocationCity": "Guangzhou",
            "LocationState": "Guangdong",
            "LocationZip": "510630",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Qi Zhang, Doctor",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000017093",
            "ConditionMeshTerm": "Liver Failure"
          },
          {
            "ConditionMeshId": "D000048550",
            "ConditionMeshTerm": "Hepatic Insufficiency"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000008107",
            "ConditionAncestorTerm": "Liver Diseases"
          },
          {
            "ConditionAncestorId": "D000004066",
            "ConditionAncestorTerm": "Digestive System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M18567",
            "ConditionBrowseLeafName": "Liver Failure",
            "ConditionBrowseLeafAsFound": "Liver Failure",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M25123",
            "ConditionBrowseLeafName": "Hepatic Insufficiency",
            "ConditionBrowseLeafAsFound": "Liver Failure",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10259",
            "ConditionBrowseLeafName": "Liver Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8035",
            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6407",
            "ConditionBrowseLeafName": "Digestive System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC06",
            "ConditionBrowseBranchName": "Digestive System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000000998",
            "InterventionMeshTerm": "Antiviral Agents"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000000890",
            "InterventionAncestorTerm": "Anti-Infective Agents"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M20396",
            "InterventionBrowseLeafName": "Lamivudine",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M10262",
            "InterventionBrowseLeafName": "Liver Extracts",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3466",
            "InterventionBrowseLeafName": "Antiviral Agents",
            "InterventionBrowseLeafAsFound": "Sensitive to",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M230376",
            "InterventionBrowseLeafName": "Entecavir",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M34170",
            "InterventionBrowseLeafName": "Polyene phosphatidylcholine",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M219479",
            "InterventionBrowseLeafName": "Adefovir",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M341471",
            "InterventionBrowseLeafName": "Adefovir dipivoxil",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3366",
            "InterventionBrowseLeafName": "Anti-Infective Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "T404",
            "InterventionBrowseLeafName": "Lecithin",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Infe",
            "InterventionBrowseBranchName": "Anti-Infective Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          },
          {
            "InterventionBrowseBranchAbbrev": "Hemat",
            "InterventionBrowseBranchName": "Hematinics"
          },
          {
            "InterventionBrowseBranchAbbrev": "Lipd",
            "InterventionBrowseBranchName": "Lipid Regulating Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "Ot",
            "InterventionBrowseBranchName": "Other Dietary Supplements"
          }
        ]
      }
    }
  }
}